Ventas, Inc. INFORMATION TABLE, Q2 FY2026

Ventas, Inc. - Form 13F Information Table Summary

Business Context and Reporting Period

This filing is a Form 13F Information Table submitted to the SEC. The reporting period or date indicated in the metadata is June 30, 2026. The filing discloses holdings of a specific issuer, Ardent Health, Inc., rather than providing financial results for Ventas, Inc. itself.

Key Financial Metrics

The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics for Ventas, Inc. or Ardent Health, Inc. Form 13F filings are designed to report securities holdings and voting authority, not operational financial performance.

Material Changes

The filing text does not provide data for the prior comparable period; therefore, no material changes can be calculated or reported based on this document.

Guidance, Outlook, and Risks

The filing contains no management commentary, guidance, outlook, risks, contingencies, or unusual items. It strictly lists the securities held.

Investor Verification Points

  • Issuer Held: Ardent Health, Inc. (Common Stock, CUSIP 03980N107).
  • Share Quantity: 9,342,501 shares.
  • Value: $91,930,210 (to the nearest dollar).
  • Voting Authority: Sole discretion (9,342,501 shares); Shared and None are 0.
  • Investment Type: Principal Amount (PRN).